Douglas J. Williamson
CIK: 0001911501
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VTGN
Vistagen Therapeutics, Inc.
Discretionary Trading P&L
Holdings
About Williamson Douglas J
Williamson Douglas J (SEC CIK 0001911501) files insider reports with the SEC as Vistagen Therapeutics, Inc. (VTGN).
Signal8 holds 2 ownership filings by Williamson Douglas J (1 Form 3, 1 Form 4), filed on Jul 31, 2026. Those filings report 1 transaction, the latest on Jul 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Williamson Douglas J's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Williamson Douglas J
- Jul 29, 2026: Grant or award of VTGN derivative securities (Form 4, code A).
Other insiders filing for Vistagen Therapeutics, Inc. (VTGN)
- Adler Reid G., Chief Legal Officer
- Tressler Nick B., Chief Financial Officer
- Singh Shawn, President and CEO
- Angelov Angel S, Chief Medical Officer
- Prince Joshua S., Chief Operating Officer
- Cote Elissa S., Chief Corp Development Officer